AMOXAPINE Side Effects

5934224-9 | Abnormal Behaviour, Alcohol Use, Amnesia, Confusional State, Decreased Appetite, Dysuria, Headache, Hot Flush
on Oct 28, 2008 Female patient from UNITED STATES , 56 years of age, weighting 166.4 lb, was diagnosed with depression (What is depression?) and was treated with Amoxapine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, alcohol use, amnesia, confusional state, decreased appetite, dysuria, headache (What is headache?), hot flush. Amoxapine dosage: 100 Mg Nightly Po. During the same period patient was treated with SEROQUEL (100 Mg Nightly Po) (View Seroquel Review and Seroquel Label ), PAXIL (40 Mg Nightly Po) (View Paxil Review and Paxil Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

5705317-6 | Acute Respiratory Distress Syndrome
Patient was taking Amoxapine (View Usage). Patient had the following side effects: acute respiratory distress syndrome on Apr 02, 2008 from JAPAN Additional patient health information: Female patient , 37 years of age, was diagnosed with depression (What is depression?) and. Amoxapine dosage: 75 Mg, Daily, Oral. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ). Patient was hospitalized.

5615438-4 | Acute Respiratory Distress Syndrome, Alanine Aminotransferase Increased, Alcohol Use, Anaemia, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Lung Infiltration, Lymphocytosis, Neutrophilia
Adverse event was reported on Jan 21, 2008 by a Female patient taking Amoxapine (View Usage) (Dosage: 2.5 Mg, Qd, 25 Mg, Qd, 75 Mg, Qd) was diagnosed with bipolar i disorder and. Location: JAPAN , 37 years of age, After Amoxapine was administered, patient had the following side effects: acute respiratory distress syndrome, alanine aminotransferase increased, alcohol use, anaemia, aspartate aminotransferase increased, gamma-glutamyltransferase increased, lung infiltration, lymphocytosis, neutrophilia. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SULBACTAM (SULBACTAM) (View Sulbactam (sulbactam) Review and Sulbactam (sulbactam) Label ). Patient was hospitalized.

5563798-5 | Eating Disorder, Gait Disturbance, Laziness, Neuroleptic Malignant Syndrome
on Oct 25, 2007 Male patient from JAPAN , 44 years of age, was diagnosed with major depression, insomnia and was treated with Amoxapine (View Usage). Patient experienced the following unwanted or unexpected effects: eating disorder (What is eating disorder?), gait disturbance, laziness, neuroleptic malignant syndrome. Amoxapine dosage: 75 Mg. During the same period patient was treated with BROTIZOLAM (Unk) (View Brotizolam Review and Brotizolam Label ), MYSLEE (10 Mg) (View Myslee Review and Myslee Label ). Patient was hospitalized.


5508192-8 | Eating Disorder, Gait Disturbance, Neuroleptic Malignant Syndrome, Overdose, Somnolence
on Oct 25, 2007 Male patient from JAPAN , 44 years of age, was diagnosed with major depression, insomnia and was treated with Amoxapine (View Usage). Patient had the following side effects: eating disorder (What is eating disorder?), gait disturbance, neuroleptic malignant syndrome, overdose, somnolence. Amoxapine dosage: 75 Mg. During the same period patient was treated with BROTIZOLAM (Unk) (View Brotizolam Review and Brotizolam Label ), ZOLPIDEM (10 Mg) (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

5302442-9 | Cardiac Failure Chronic, Completed Suicide, Intentional Overdose, Intentional Self-injury, Pulmonary Congestion, Pulmonary Oedema, Skin Laceration
Patient was taking Amoxapine (View Usage). After Amoxapine was administered, patient had the following side effects: cardiac failure chronic, completed suicide, intentional overdose, intentional self-injury, pulmonary congestion, pulmonary oedema, skin laceration on Apr 03, 2007 from JAPAN Additional patient health information: Female patient , 43 years of age, weighting 125.7 lb, was diagnosed with depression (What is depression?) and. Amoxapine dosage: Oral. During the same period patient was treated with ANTIDEPRESSANTS (NO INGREDIENTS/SUBSTANCES) (View Antidepressants (no Ingredients/substances) Review and Antidepressants (no Ingredients/substances) Label ), ANTIPSYCHOTICS (NO INGREDIENTS/SUBSTANCES) (View Antipsychotics (no Ingredients/substances) Review and Antipsychotics (no Ingredients/substances) Label ), ANXIOLYTICS (NO INGREDIENTS/SUBSTANCES) (View Anxiolytics (no Ingredients/substances) Review and Anxiolytics (no Ingredients/substances) Label ), HYPNOTICS AND SEDATIVES (NO INGREDIENTS/SUBSTANCES) (View Hypnotics And Sedatives (no Ingredients/substances) Review and Hypnotics And Sedatives (no Ingredients/substances) Label ).

4559510-9 | Blood Caffeine Increased, Intentional Misuse, Overdose, Serotonin Syndrome
Adverse event was reported on Jan 04, 2005 by a Female patient taking Amoxapine (View Usage) (Dosage: 200 Mg X 1 , Oral) was diagnosed with depression (What is depression?) and. Location: , 30 years of age, Patient experienced the following unwanted or unexpected effects: blood caffeine increased, intentional misuse, overdose, serotonin syndrome. During the same period patient was treated with CAFFEINE(CAFFEINE) (4.8 Grams X 1, Oral) (View Caffeine(caffeine) Review and Caffeine(caffeine) Label ), PAROXETINE(PAROXETINE) 20MG (1 Tablet X 1 , Oral) (View Paroxetine(paroxetine) 20mg Review and Paroxetine(paroxetine) 20mg Label ). Patient was hospitalized.